U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791901) titled 'MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial' on Aug. 06.
Brief Summary: This pilot clinical trial will study psilocybin-assisted therapy for adults with advanced cancer who are experiencing demoralization, existential distress, or related psychological concerns. Demoralization can include feelings of hopelessness, helplessness, loss of meaning, and distress related to illness or end of life.
The purpose of this study is to assess whether a hybrid group-based psilocybin-assisted therapy program is feasible, acceptable, and safe in adults with advanced cancer. The study will also explore which combination of psilo...